You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

AUL

Showing 1 - 25 of 37
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Living With Adult Upper Limb Spasticity and to Assess Arm

Recruiting
  • Spastic Hemiparesis
  • Muscle Spasticity
    • Downey, California
      Rancho Los Amigos National Rehab
    Dec 9, 2022

    Myelodysplastic Syndrome (MDS), Chronic Lymphocytic Leukemia (CLL), Chemo-sensitive Lymphoma Trial in United States (drug,

    Completed
    • Myelodysplastic Syndrome (MDS)
    • +6 more
    • Gainesville, Florida
    • +10 more
    Nov 30, 2020

    Poor Graft Function Trial (Decitabine, Granulocyte Colony-Stimulating Factor, Thrombopoietin Receptor Agonist)

    Not yet recruiting
    • Poor Graft Function
    • (no location specified)
    Jun 8, 2023

    Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial (drug, radiation, procedure)

    Not yet recruiting
    • Acute Leukemia
    • +4 more
    • (no location specified)
    Oct 18, 2022

    MDS Trial in Beijing (Lenalidomide, Azacitidine)

    Not yet recruiting
    • Myelodysplastic Syndromes
    • Beijing, China
      Peking union medical college hospital
    Aug 16, 2023

    Spasticity Trial in Worldwide (IPN10200, Placebo, Dysport)

    Recruiting
    • Spasticity
    • IPN10200
    • +2 more
    • Linz, Austria
    • +40 more
    Dec 16, 2022

    Acute Leukemia, MDS, T-lymphoblastic Lymphoma Trial (drug, radiation, procedure)

    Not yet recruiting
    • Acute Leukemia
    • +6 more
    • (no location specified)
    Dec 8, 2021

    The Acute Promyelocytic Leukaemia Asian Consortium Project

    Recruiting
    • Acute Promyelocytic Leukemia
      • Hong Kong, Hong Kong
        Department of Medicine, the University of Hong Kong, Queen Mary
      Oct 3, 2022

      It's Not JUST Idiopathic Pulmonary Fibrosis Study

      Recruiting
      • Interstitial Lung Disease
      • Idiopathic Pulmonary Fibrosis
      • Optional Bronchoscopy
      • +3 more
      • Burton on Trent, Derbyshire, United Kingdom
      • +23 more
      Jul 1, 2021

      Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid

      Active, not recruiting
      • Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
      • +9 more
      • Sewell, New Jersey
      • +4 more
      Dec 13, 2022

      Myelodysplastic Syndrome Trial in France, Germany, Spain (Lenalidomide, Placebo)

      Active, not recruiting
      • Myelodysplastic Syndrome
      • Strasbourg, Bajo Rin, France
      • +24 more
      Nov 22, 2021

      Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b) Trial

      Completed
      • Adult Acute Megakaryoblastic Leukemia (M7)
      • +13 more
      • Philadelphia, Pennsylvania
        Thomas Jefferson University
      Feb 2, 2023

      Mature B-Cell Leukemia Burkitt Type, Burkitt Lymphoma (BL), Unclassifiable Lymphoma Between DCBL and BL Trial in Spain

      Recruiting
      • Mature B-Cell Leukemia Burkitt Type
      • +2 more
      • Badalona, Barcelona, Spain
      • +28 more
      Sep 17, 2021

      Myelodysplastic Syndromes Not Candidates for Allogeneic

      Unknown status
      • Myelodysplastic Syndromes
      • Azacitidine Injection [Vidaza]
      • Palma, Islas Baleares, Spain
        Son Llàtzer
      Oct 20, 2020

      Acute Promyelocytic Leukemia Trial in Hong Kong (Oral Arsenic Trioxide Formulation)

      Recruiting
      • Acute Promyelocytic Leukemia
      • Oral Arsenic Trioxide Formulation
      • Hong Kong, Hong Kong
        The University of Hong Kong
      Dec 29, 2020

      Active Systemic Lupus Erythematosus Trial in Worldwide (Anifrolumab, Placebo)

      Completed
      Has Results
      • Active Systemic Lupus Erythematosus
      • Anifrolumab
      • Placebo
      • Birmingham, Alabama
      • +145 more
      Nov 18, 2019

      GENOMED4ALL: Improving MDS Classification and Prognosis by AI

      Active, not recruiting
      • Myelodysplastic Syndromes
        • Milano, Italy
          Istituto Clinico Humanitas
        Jun 28, 2021

        Myeldysplastic Syndrome (MDS), Chronic Myelomonocytic Leukemia, Bone Marrow Diseases Trial run by the NHLBI (Clofarabine,

        Completed
        • Myeldysplastic Syndrome (MDS)
        • +4 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center, 9000 Rockville Pi
        Dec 14, 2019

        Hematological Malignancies Trial in Bologna (Intrabone cord blood infusion)

        Completed
        • Hematological Malignancies
        • Intrabone cord blood infusion
        • Bologna, Italy
          Hematology Institute "L. and A. Seràgnoli", S. Orsola-Malpighi U
        Mar 18, 2021

        Myelodysplastic Syndrome (MDS) Trial run by the NHLBI (ON 01910 Na)

        Completed
        • Myelodysplastic Syndrome (MDS)
        • ON 01910 Na
        • Bethesda, Maryland
          National Institutes of Health Clinical Center, 9000 Rockville Pi
        Dec 14, 2019

        MDS, CMML Trial in Florence (CC-486)

        Recruiting
        • MDS
        • CMML
        • Florence, Italy
          AOU Careggi- University of Florence
        Mar 16, 2021

        l Research in Myelodysplastic Syndromes

        Recruiting
        • Myelodysplastic Syndromes
          • Paris, France
          • +3 more
          Nov 20, 2019

          Chronic Myelomonocytic Leukemia, Chronic Myelogenous Leukemia Trial run by the NHLBI (Imatinib)

          Completed
          • Chronic Myelomonocytic Leukemia
          • Chronic Myelogenous Leukemia
          • Bethesda, Maryland
            National Institutes of Health Clinical Center, 9000 Rockville Pi
          Jun 30, 2017

          Myelodysplastic Syndrome Trial in New York (ON 01910.Na Concentrate)

          Withdrawn
          • Myelodysplastic Syndrome
          • ON 01910.Na Concentrate
          • New York, New York
            Memorial Sloan-Kettering Cancer Center
          Jun 22, 2017

          Hemochromatosis, MDS Trial in Bergen (Deferasirox, Venesection)

          Terminated
          • Hemochromatosis
          • Myelodysplastic Syndromes
          • Bergen, Norway
            Haukeland University Hospital, Clinical Trial Unit
          Jan 20, 2017